Advisortrust Partners’s AstraZeneca AZN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$5.37M Buy
33,282
+4,998
+18% +$833K 1.69% 16
2026
Q2
$5.36M Buy
28,284
+26,906
+1,953% +$5.06M 1.83% 14
2026
Q1
$272K Sell
1,378
-100
-7% -$19.3K 0.11% 143
2025
Q4
$272K Buy
+1,478
New +$259K 0.12% 126

Other funds holding AZN

Advisortrust Partners's AZN Position: Q3 2026 in Review

Advisortrust Partners increased its AstraZeneca (AZN) stake by 18% in Q3 2026, buying an estimated $833K and bringing the position to 33,282 shares worth $5.37M. The position accounts for 1.69% of the portfolio, ranked #16.

Advisortrust Partners first reported a position in AZN in Q4 2025 and has held it in 4 quarters since. 1,446 funds tracked by Wall St. Rank hold AZN as of Q3 2026.

  • Advisortrust Partners held 33,282 shares of AstraZeneca worth $5.37M as of Q3 2026.
  • Advisortrust Partners bought 4,998 AstraZeneca shares in Q3 2026, an estimated $833K.
  • AstraZeneca made up 1.69% of Advisortrust Partners's portfolio in Q3 2026, its #16 holding.
  • Advisortrust Partners first reported a position in AstraZeneca in Q4 2025 and has held it in 4 quarters since.
  • 1,446 funds tracked by Wall St. Rank held AstraZeneca as of Q3 2026.

Based on Advisortrust Partners's 13F filing for Q3 2026, filed 2 Nov 2026.